tiprankstipranks
Trending News
More News >
SAB Biotherapeutics (SABS)
NASDAQ:SABS
US Market

SAB Biotherapeutics (SABS) Ownership - Who Owns SAB Biotherapeutics?

Compare
307 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2025
xxxxxxxxxxxxx
$5730270
Sep 30, 2025
xxxxxxxxxxxxx
$8847015

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
5,232,304Insider10.99%21,086,185
4,401,500Institution9.25%17,738,045
2,857,142Insider6.00%11,514,282
2,850,881Institution5.99%11,489,050
2,198,457Insider4.62%8,859,782
2,198,457Insider4.62%8,859,782
1,717,280Institution3.61%6,920,638
766,699Insider1.61%3,089,797
304,080Institution0.64%1,225,442
208,227Institution0.44%839,155

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
304,080Institution0.64%1,225,442
71,410Institution0.15%287,782
3,669Institution<0.01%14,786

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,640,793Institution3.45%6,136,566
208,227Institution0.44%839,155
76,487Institution0.16%286,061
15,014Institution0.03%60,206

FAQ

Who Owns SAB Biotherapeutics (SABS)?
Currently, no data Available
What percentage of SAB Biotherapeutics (SABS) stock is held by institutional investors?
Currently, no data Available
What percentage of SAB Biotherapeutics (SABS) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of SAB Biotherapeutics (SABS)?
Eddie Joe Sullivan owns the most shares of SAB Biotherapeutics (SABS).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.